Cas:590354-46-4 4-ethyl-3-[(4-methoxyphenyl)methyl]-1H-1,2,4-triazole-5-thione manufacturer & supplier

Chemical Name:4-ethyl-3-[(4-methoxyphenyl)methyl]-1H-1,2,4-triazole-5-thione

CAS.NO:590354-46-4

Synonyms:4-ethyl-3-[(4-methoxyphenyl)methyl]-1H-1,2,4-triazole-5-thione

Molecular Formula:C₁₂H₁₅N₃OS

Molecular Weight:249.33200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:357ºC at 760 mmHg

Density:1.23g/cm3

Index of Refraction:1.62

PSA:78.74000

Exact Mass:249.09400

LogP:2.18610

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-ethyl-3-[(4-methoxyphenyl)methyl]-1H-1,2,4-triazole-5-thione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-ethyl-3-[(4-methoxyphenyl)methyl]-1H-1,2,4-triazole-5-thione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-ethyl-3-[(4-methoxyphenyl)methyl]-1H-1,2,4-triazole-5-thione Use and application,4-ethyl-3-[(4-methoxyphenyl)methyl]-1H-1,2,4-triazole-5-thione technical grade,usp/ep/jp grade.

Related News: Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. 4-ethyl-3-[(4-methoxyphenyl)methyl]-1H-1,2,4-triazole-5-thione manufacturer Taiwan previously participated as an observer at the World Health Assembly, the W.H.O.��s governing body. 4-ethyl-3-[(4-methoxyphenyl)methyl]-1H-1,2,4-triazole-5-thione supplier Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. 4-ethyl-3-[(4-methoxyphenyl)methyl]-1H-1,2,4-triazole-5-thione vendor Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. 4-ethyl-3-[(4-methoxyphenyl)methyl]-1H-1,2,4-triazole-5-thione factory Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching.